INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 54 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $11,000 | -21.4% | 4,444 | -45.4% | 0.00% | – |
| Q3 2017 | $14,000 | +27.3% | 8,144 | +24.1% | 0.00% | – |
| Q2 2017 | $11,000 | +22.2% | 6,560 | +27.4% | 0.00% | – |
| Q1 2017 | $9,000 | -92.7% | 5,150 | -74.6% | 0.00% | – |
| Q4 2016 | $123,000 | -60.6% | 20,291 | -38.8% | 0.00% | – |
| Q3 2016 | $312,000 | +155.7% | 33,165 | +98.1% | 0.00% | – |
| Q2 2016 | $122,000 | -43.8% | 16,743 | -43.1% | 0.00% | – |
| Q1 2016 | $217,000 | -35.0% | 29,433 | -0.5% | 0.00% | – |
| Q4 2015 | $334,000 | +255.3% | 29,585 | +195.8% | 0.00% | – |
| Q3 2015 | $94,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|